Immunoadsorption in nephrotic syndrome: Where are we now and where are we going from here?
Kronbichler A, Gauckler P, Lee K, Shin J, Malvezzi P, Mayer G. Immunoadsorption in nephrotic syndrome: Where are we now and where are we going from here? Atherosclerosis Plus 2019, 40: 55-60. PMID: 31447217, DOI: 10.1016/j.atherosclerosissup.2019.08.027.Peer-Reviewed Original ResearchConceptsIdiopathic nephrotic syndromeFocal segmental glomerulosclerosisPlasma exchangeMembranous nephropathyNephrotic syndromeKidney transplantationManagement of idiopathic nephrotic syndromeThrombospondin type-1 domain-containing 7AClinical trialsPrimary focal segmental glomerulosclerosisPhase II clinical trialPhospholipase A2 receptorTreatment-resistant casesAbsence of genetic testingII clinical trialsTreatment formsPrescribed immunosuppressive drugsRemission ratePLA2R-AbPrimary MNImmunosuppressive drugsLDL apheresisA2 receptorsSafety profileTreatment options
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply